Healthcare -
Biotechnology - NASDAQ - US
$ 28.54
-6.36 %
$ 173 M
Market Cap
-14.41
P/E
MNPR - STOCK-BASED COMPENSATION
Stock-based Compensation MNPR - Monopar Therapeutics Inc.
1.9 M
LAST VALUE
13.70%
2 YEAR CAGR
29.09%
5 YEAR CAGR
0.00%
10 YEAR CAGR